ReviewDrugs in context2018
Advances in the use of PARP inhibitor therapy for breast cancer.
Kelly E McCann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
69 papers cite itlatest 60 shown
this paperpooled itcites it
ReviewDrugs in context2018
Kelly E McCann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.